Schistosome vaccines: A critical appraisal

Memorias do Instituto Oswaldo Cruz

Volumn 101, Issue SUPPL. 1, 2006, Pages 13-20

  Wilson, R Alan ^a   Coulson, Patricia S ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Antigen; Formulation; Immune response; Protection

Indexed keywords

RODENTIA; SCHISTOSOMA; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMA MANSONI;

EID: 33846462491     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762006000900004     Document Type: Conference Paper

References (75)

1. Ali PO, Jeffs SA, Meadows HM, Hollyer T, Owen CA, Abath FG, Allen R, Hackett F, Smithers SR, Simpson AJ 1991. Structure of Sm25, an antigenic integral membrane glycoprotein of adult Schistosoma mansoni. Mol Biochem Parasitol 45: 215-222.
2. Ashton PD, Curwen RS, Wilson RA 2001. Linking proteome and genome: how to identify parasite proteins. Trends Parasitol 17: 198-202.
3. Auriault C, Gras-Masse H, Wolowczuk I, Pierce RJ, Balloul JM, Neyrinck JL, Drobecq H, Tartar A, Capron A 1988. Analysis of T and B cell epitopes of the Schistosoma mansoni P28 antigen in the rat model by using synthetic peptides. J Immunol 141: 1687-1694.
4. Balloul JM, Pierce RJ, Grzych JM, Capron A 1985. In vitro synthesis of a 28 kilodalton antigen present on the surface of the schistosomulum of Schistosoma mansoni. Mol Biochem Parasitol 17: 105-114.
5. Baras B, Benoit MA, Dupre L, Poulain-Godefroy O, Schacht AM, Capron A, Gillard J, Riveau G 1999. Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen. Infect Immun 67: 2643-2648.
6. Berg P, Baltimore D, Boyer HW, Cohen SN, Davis RW, Hogness DS, Nathans D, Roblin R, Watson JD, Weissman S, Zinder ND 1974. Letter: Potential biohazards of recombinant DNA molecules. Science 185: 303.
7. Boulanger D, Warter A, Trottein F, Mauny F, Bremond P, Audibert F, Couret D, Kadri S, Godin C, Sellin E et al. 1995. Vaccination of patas monkeys experimentally infected with Schistosoma haematobium using a recombinant glutathione S-transferase cloned from S. mansoni. Parasite Immunol 17: 361-369.
8. Braschi S, Wilson RA 2006. Proteins exposed at the adult schistosome surface revealed by biotinylation. Mol Cell Proteomics 5: 347-356.
9. Braschi S, Borges W, Wilson RA 2006b. Proteomic analysis of the schistosome tegument and its surface membranes. Mem Inst Oswaldo Cruz 101(Suppl.): 167-174.
10. Braschi S, Curwen RS, Ashton PD, Verjovski-Almeida S, Wilson A 2006a. The tegument surface membranes of the human blood parasite Schistosoma mansoni: a proteomic analysis after differential extraction. Proteomics 6: 1471-1482.
11. Butterworth AE 1984. Cell-mediated damage to helminths. Adv Parasitol 23: 143-235.
12. Butterworth AE, Sturrock RF, Houba V, Rees PH 1974. Antibody-dependent cell-mediated damage to schistosomula in vitro. Nature 252: 503-505.
13. Capron A, Capron M, Riveau G 2002. Vaccine development against schistosomiasis from concepts to clinical trials. Br Med Bull 62: 139-148.
14. Capron A, Riveau G, Capron M, Trottein F 2005. Schistosomes: the road from host-parasite interactions to vaccines in clinical trials. Trends Parasitol 21: 143-149.
15. Coulson PS 1997. The radiation-attenuated vaccine against schistosomes in animal models: paradigm for a human vaccine? Adv Parasitol 39: 271-336.
16. Coulson PS, Wilson RA 1997. Recruitment of lymphocytes to the lung through vaccination enhances the immunity of mice exposed to irradiated schistosomes. Infect Immun 65: 42-48.
17. Curwen RS, Ashton PD, Johnston DA, Wilson RA 2004. The Schistosoma mansoni soluble proteome: a comparison across four life-cycle stages. Mol Biochem Parasitol 138: 57-66.
18. Curwen RS, Ashton PD, Sundaralingam S, Wilson RA 2006. Identification of novel proteases and immunomodulators in the secretions of schistosome cercariae that facilitate host entry. Mol Cell Proteomics 5: 835-844.
19. Dean DA, Minard P, Murrell KD, Vannier WE 1978a. Resistance of mice to secondary infection with Schistosoma mansoni. II. Evidence for a correlation between egg deposition and work elimination. Am J Trop Med Hyg 27: 957-965.
20. Dean DA, Minard P, Stirewalt MA, Vannier WE, Murrell KD 1978b. Resistance of mice to secondary infection with Schistosoma mansoni. I. Comparison of bisexual and unisexual initial infections. Am J Trop Med Hyg 27: 951-956.
21. Dessein AJ, Begley M, Demeure C, Caillol D, Fueri J, dos Reis MG, Andrade ZA, Prata A, Bina JC 1988. Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigen. J Immunol 140: 2727-2736.
22. Dillon GP, Feltwell T, Skelton JP, Ashton PD, Coulson PS, Quail MA, Nikolaidou-Katsaridou N, Wilson RA, Ivens AC 2006. Microarray analysis identifies genes preferentially expressed in the lung schistosomulum of Schistosoma mansoni. Int J Parasitol 36: 1-8.
23. Doenhoff MJ, Kusel JR, Coles GC, Cioli D 2002. Resistance of Schistosoma mansoni to praziquantel: is there a problem? Trans R Soc Trop Med Hyg 96: 465-469.
24. Doenhoff MJ, Sabah AA, Fletcher C, Webbe G, Bain J 1987. Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice. Trans R Soc Trop Med Hyg 81: 947-951.
25. Dupre L, Kremer L, Wolowczuk I, Riveau G, Capron A, Locht C 2001. Immunostimulatory effect of IL-18-encoding plasmid in DNA vaccination against murine Schistosoma mansoni infection. Vaccine 19: 1373-1380.
26. Eberl M, Langermans JA, Frost PA, Vervenne RA, van Dam GJ, Deelder AM, Thomas AW, Coulson PS, Wilson RA 2001. Cellular and humoral immune responses and protection against schistosomes induced by a radiation-attenuated vaccine in chimpanzees. Infect Immun 69: 5352-5362.
27. Goudot-Crozel V, Caillol D, Djabali M, Dessein AJ 1989. The major parasite surface antigen associated with human resistance to schistosomiasis is a 37-kD glyceraldehyde-3P-dehydrogenase. J Exp Med 170: 2065-2080.
28. Grzych JM, Capron M, Lambert PH, Dissous C, Torres S, Capron A 1985. An anti-idiotype vaccine against experimental schistosomiasis. Nature 316: 74-76.
29. Hagan P, Blumenthal UJ, Dunn D, Simpson AJ, Wilkins HA 1991. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 349: 243-245.
30. Hall SL 2005. The Use of Proteomic Techniques to Identify Antibody Ttargets in Schistosomiasis, PhD thesis, University of York, York.
31. Harn DA, Gu W, Oligino LD, Mitsuyama M, Gebremichael A, Richter D 1992. A protective monoclonal antibody specifically recognizes and alters the catalytic activity of schistosome triose-phosphate isomerase. J Immunol 148: 562-567.
32. Harris AR, Russell RJ, Charters AD 1984. A review of schistosomiasis in immigrants in Western Australia, demonstrating the unusual longevity of Schistosoma mansoni. Trans R Soc Trop Med Hyg 78: 385-388.
33. Harrison RA, Bickle Q, Doenhoff MJ 1982. Factors affecting the acquisition of resistance against Schistosoma mansoni in the mouse. Evidence that the mechanisms which mediate resistance during early patent infections may lack immunological specificity. Parasitology 84: 93-110.
34. Harrop R, Coulson PS, Wilson RA 1999. Characterization, cloning and immunogenicity of antigens released by lung-stage larvae of Schistosoma mansoni. Parasitology 118 (Pt 6): 583-594.
35. Harrop R, Jennings N, Mountford AP, Coulson PS, Wilson RA 2000. Characterization, cloning and immunogenicity of antigens released by transforming cercariae of Schistosoma mansoni. Parasitology 121 (Pt 4): 385-394.
36. Hayunga EG 1985. Attempted immunization of mice against S. mansoni by inoculation with purified glycoprotein antigens from adult worms. Proc Helminth Soc 52: 184-195.
37. Hazdai RT, Levi-Schaffer F, Brenner V, Horowitz S, Eshhar Z, Arnon R 1985. Protective monoclonal antibody against Schistosoma mansoni: antigen isolation, characterization, and suitability for active immunization. J Immunol 135: 2772-2779.
38. James SL, DeBlois LA 1986. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. II. Response of mouse strains with selective immune defects. J Immunol 136: 3864-3871.
39. Kariuki TM, Farah IO, Yole DS, Mwenda JM, Van Dam GJ, Deelder AM, Wilson RA, Coulson PS 2004. Parameters of the attenuated schistosome vaccine evaluated in the olive baboon. Infect Immun 72: 5526-5529.
40. Khan CM, Villarreal-Ramos B, Pierce RJ, Riveau G, Demarco de Hormaeche R, McNeill H, Ali T, Fairweather N, Chatfield S, Capron A et al. 1994. Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. Proc Natl Acad Sci U S A 91: 11261-11265.
41. King CH, Dickman K, Tisch DJ 2005. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365: 1561-1569.
42. Knopf PM, Srivastava BS, Barker Jr. RH 1982. Application of cloning techniques to development of a synthetic vaccine against schistosomiasis. Vet Parasitol 10: 255-259.
43. Kohler G, Milstein C 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495-497.
44. Kremer L, Riveau G, Baulard A, Capron A, Locht C 1996. Neutralizing antibody responses elicited in mice immunized with recombinant bacillus Calmette-Guerin producing the Schistosoma mansoni glutathione S-transferase. J Immunol 156: 4309-4317.
45. McCullough FS, Bradley DJ 1973. Egg output stability and the epidemiology of Schistosoma haematobium. I. Variation and stability in Schistosoma haematobium egg counts. Trans R Soc Trop Med Hyg 67: 475-490.
46. McLaren DJ, Hockley DJ 1976. Schistosoma mansoni: the occurrence of microvilli on the surface of the tegument during transformation from cercaria to schistosomulum. Parasitology 73: 169-187.
47. Mielcarek N, Cornette J, Schacht AM, Pierce RJ, Locht C, Capron A, Riveau G 1997. Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen. Infect Immun 65: 544-550.
48. Minard P, Dean DA, Jacobson RH, Vannier WE, Murrell KD 1978. Immunization of mice with cobalt-60 irradiated Schistosoma mansoni cercariae. Am J Trop Med Hyg 27: 76-86.
49. Moser D, Tendler M, Griffiths G, Klinkert MQ 1991. A 14-kDa Schistosoma mansoni polypeptide is homologous to a gene family of fatty acid binding proteins. J Biol Chem 266: 8447-8454.
50. Mountford AP, Anderson S, Wilson RA 1996. Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant. J Immunol 156: 4739-4745.
51. Mullis K, Faloona F, Scharf S, Saiki R, Horn G, Erlich H 1986. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp Quant Biol 51 (Pt 1): 263-273.
52. Murrell KD, Dean DA, Stafford EE 1975. Resistance to infection with Schistosoma mansoni after immunization with worm extracts or live cercariae: role of cytotoxic antibody in mice and guinea pigs. Am J Trop Med Hyg 24: 955-962.
53. Olds GR, Kresina TF 1987. Protective anti-idiotype vaccine against Schistosoma mansoni infection. Trans Assoc Am Physicians 100: 215-221.
54. Pearce EJ, James SL, Hieny S, Lanar DE, Sher A 1988. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen. Proc Natl Acad Sci USA 85: 5678-5682.
55. Ramaswamy K, Salafsky B, Potluri S, He YX, Li JW, Shibuya T 1995. Secretion of an anti-inflammatory, immunomodulatory factor by Schistosomulae of Schistosoma mansoni. J Inflamm 46: 13-22.
56. Reynolds SR, Shoemaker CB, Harn DA 1992. T and B cell epitope mapping of SM23, an integral membrane protein of Schistosoma mansoni. J Immunol 149: 3995-4001.
57. Sadun EH, Lin SS 1959. Studies on the host parasite relationships to Schistosoma japonicum. IV. Resistance acquired by infection, by vaccination and by the injection of immune serum, in monkeys, rabbits and mice. J Parasitol 45: 543-548.
58. Salter JP, Choe Y, Albrecht H, Franklin C, Lim KC, Craik CS, McKerrow JH 2002. Cercarial elastase is encoded by a functionally conserved gene family across multiple species of schistosomes. J Biol Chem 277: 24618-24624.
59. Sher A, Smithers SR, Mackenzie P 1975. Passive transfer of acquired resistance to Schistosoma mansoni in laboratory mice. Parasitology 70 Part 3: 347-357.
60. Silveira AM, Gazzinelli G, Alves-Oliveira LF, Bethony J, Gazzinelli A, Carvalho-Queiroz C, Alvarez MC, Lima-Silva FC, Prata A, LoVerde PT, Correa-Oliveira R 2004. Human schistosomiasis mansoni: intensity of infection differentially affects the production of interleukin-10, interferongamma and interleukin-13 by soluble egg antigen or adult worm antigen stimulated cultures. Trans R Soc Trop Med Hyg 98: 514-519.
61. Skelly, PM, Wilson RA 2006. Making sense of the schistosome surface. Adv Parasitol in press.
62. Smithers SR, Terry RJ 1969. Immunity in schistosomiasis. Ann NY Acad Sci 160: 826-840.
63. Smythies LE, Coulson PS, Wilson RA 1992. Monoclonal antibody to IFN-gamma modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae. J Immunol 149: 3654-3658.
64. Soisson LM, Masterson CP, Tom TD, McNally MT, Lowell GH, Strand M 1992. Induction of protective immunity in mice using a 62-kDa recombinant fragment of a Schistosoma mansoni surface antigen. J Immunol 149: 3612-3620.
65. Street M, Coulson PS, Sadler C, Warnock LJ, McLaughlin D, Bluethmann H, Wilson RA 1999. TNF is essential for the cell-mediated protective immunity induced by the radiation-attenuated schistosome vaccine. J Immunol 163: 4489-4494.
66. Sun JB, Mielcarek N, Lakew M, Grzych JM, Capron A, Holmgren J, Czerkinsky C 1999. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice. J Immunol 163: 1045-1052.
67. Taylor JB, Vidal A, Torpier G, Meyer DJ, Roitsch C, Balloul JM, Southan C, Sondermeyer P, Pemble S, Lecocq JP et al. 1988. The glutathione transferase activity and tissue distribution of a cloned Mr28K protective antigen of Schistosoma mansoni. Embo J 7: 465-472.
68. van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, Habbema JD, Engels D 2003. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 86: 125-139.
69. Verjovski-Almeida S, DeMarco R, Martins EA, Guimaraes PE, Ojopi EP, Paquola AC, Piazza JP, Nishiyama MY, Jr., Kitajima JP, Adamson RE, Ashton PD, Bonaldo MF, Coulson PS, Dillon GP, Farias LP, Gregorio SP, Ho PL, Leite RA, Malaquias LC, Marques RC, Miyasato PA, Nascimento AL, Ohlweiler FP, Reis EM, Ribeiro MA, Sa RG, Stukart GC, Soares MB, Gargioni C, Kawano T, Rodrigues V, Madeira AM, Wilson RA, Menck CF, Setubal JC, Leite LC, Dias-Neto E 2003. Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nat Genet 35: 148-157.
70. Wilson RA, Coulson PS 2006. The development of a schistosome vaccine. In AG Maule, NJ Marks (eds), Parasitic Flatworms: Molecular Biology, Biochemistry, Immunology and Physiology, CAB International, Wallingford, UK.
71. Wilson RA, Coulson PS, McHugh SM 1983. A significant part of the 'concomitant immunity' of mice to Schistosoma mansoni is the consequence of a leaky hepatic portal system, not immune killing. Parasite Immunol 5: 595-601.
72. Wolowczuk I, Auriault C, Bossus M, Boulanger D, Gras-Masse H, Mazingue C, Pierce RJ, Grezel D, Reid GD, Tartar A et al. 1991. Antigenicity and immunogenicity of a multiple peptidic construction of the Schistosoma mansoni Sm-28 GST antigen in rat, mouse, and monkey. 1. Partial protection of Fischer rat after active immunization. J Immunol 146: 1987-1995.
73. Wynn TA, Jankovic D, Hieny S, Cheever AW, Sher A 1995. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J Immunol 154: 4701-4709.
74. Yi XY, Omer-Ali P, Kelly C, Simpson AJ, Smithers SR 1986. IgM antibodies recognizing carbohydrate epitopes shared between schistosomula and miracidia of Schistosoma mansoni that block in vitro killing. J Immunol 137: 3946-3954.
75. Zodda DM, Phillips SM 1982. Monoclonal antibody-mediated protection against Schistosoma mansoni infection in mice. J Immunol 129: 2326-2328.